{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T18:14:25Z","timestamp":1793211265103,"version":"4.5.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Med"],"DOI":"10.1038\/s43856-026-01683-7","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T09:02:18Z","timestamp":1783414938000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Quantifying cortical lesions in multiple sclerosis MRI datasets using multi-contrast post-processing and deep learning"],"prefix":"10.1038","volume":"6","author":[{"given":"Michael G.","family":"Dwyer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels","family":"Bergsland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Bartnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dejan","family":"Jakimovski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Noteboom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2504-6959","authenticated-orcid":false,"given":"Menno M.","family":"Schoonheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martijn D.","family":"Steenwijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinglan","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Clayton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7799-1485","authenticated-orcid":false,"given":"Robert","family":"Zivadinov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,7]]},"reference":[{"key":"1683_CR1","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S0140-6736(23)01473-3","volume":"403","author":"D Jakimovski","year":"2024","unstructured":"Jakimovski, D. et al. Multiple sclerosis. Lancet 403, 183\u2013202 (2024).","journal-title":"Lancet"},{"key":"1683_CR2","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1016\/j.amjmed.2020.05.049","volume":"133","author":"SL Hauser","year":"2020","unstructured":"Hauser, S. L. & Cree, B. A. C. Treatment of multiple sclerosis: a review. Am. J. Med. 133, 1380\u20131390.e2 (2020).","journal-title":"Am. J. Med."},{"key":"1683_CR3","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/S1474-4422(08)70191-1","volume":"7","author":"JJ Geurts","year":"2008","unstructured":"Geurts, J. J. & Barkhof, F. Grey matter pathology in multiple sclerosis. Lancet Neurol. 7, 841\u2013851 (2008).","journal-title":"Lancet Neurol."},{"key":"1683_CR4","first-page":"1480","volume":"39","author":"TA Fuchs","year":"2018","unstructured":"Fuchs, T. A. et al. Impact of focal white matter damage on localized subcortical gray matter atrophy in multiple sclerosis: a 5-year study. Am. J. Neuroradiol. 39, 1480\u20131486 (2018).","journal-title":"Am. J. Neuroradiol."},{"key":"1683_CR5","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1093\/brain\/awab132","volume":"144","author":"D Ontaneda","year":"2021","unstructured":"Ontaneda, D. et al. Deep grey matter injury in multiple sclerosis: a NAIMS consensus statement. Brain 144, 1974\u20131984 (2021).","journal-title":"Brain"},{"key":"1683_CR6","doi-asserted-by":"crossref","unstructured":"Eshaghi, A. et al. Progression of Regional Grey Matter Atrophy in Multiple Sclerosis. Brain 141, 1665\u20131677 (2018)","DOI":"10.1093\/brain\/awy088"},{"key":"1683_CR7","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/j.1600-0404.2006.00615.x","volume":"113","author":"L B\u00f6","year":"2006","unstructured":"B\u00f6, L., Geurts, J. J. G., M\u00f6rk, S. J. & van der Valk, P. Grey matter pathology in multiple sclerosis. Acta Neurol. Scand. 113, 48\u201350 (2006).","journal-title":"Acta Neurol. Scand."},{"key":"1683_CR8","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jns.2005.03.027","volume":"233","author":"A Kutzelnigg","year":"2005","unstructured":"Kutzelnigg, A. & Lassmann, H. Cortical lesions and brain atrophy in MS. J. Neurol. Sci. 233, 55\u201359 (2005).","journal-title":"J. Neurol. Sci."},{"key":"1683_CR9","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1093\/jnen\/62.7.723","volume":"62","author":"L B\u00f8","year":"2003","unstructured":"B\u00f8, L., Vedeler, C. A., Nyland, H. I., Trapp, B. D. & M\u00f8rk, S. J. Subpial demyelination in the cerebral cortex of multiple sclerosis patients. J. Neuropathol. Exp. Neurol. 62, 723\u2013732 (2003).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"1683_CR10","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1016\/j.neuroimage.2008.06.028","volume":"42","author":"M Calabrese","year":"2008","unstructured":"Calabrese, M. et al. Morphology and evolution of cortical lesions in multiple sclerosis. A longitudinal MRI study. NeuroImage 42, 1324\u20131328 (2008).","journal-title":"NeuroImage"},{"key":"1683_CR11","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1212\/WNL.0b013e3181a0fee5","volume":"72","author":"M Calabrese","year":"2009","unstructured":"Calabrese, M. et al. Cortical lesions in primary progressive multiple sclerosis: a 2-year longitudinal MR study. Neurology 72, 1330\u20131336 (2009).","journal-title":"Neurology"},{"key":"1683_CR12","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1007\/s00415-021-10400-4","volume":"268","author":"CA Treaba","year":"2021","unstructured":"Treaba, C. A. et al. The relevance of multiple sclerosis cortical lesions on cortical thinning and their clinical impact as assessed by 7.0-T MRI. J. Neurol. 268, 2473\u20132481 (2021).","journal-title":"J. Neurol."},{"key":"1683_CR13","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1111\/bpa.12813","volume":"30","author":"A Junker","year":"2020","unstructured":"Junker, A. et al. Extensive subpial cortical demyelination is specific to multiple sclerosis. Brain Pathol. 30, 641\u2013652 (2020).","journal-title":"Brain Pathol."},{"key":"1683_CR14","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","volume":"17","author":"AJ Thompson","year":"2018","unstructured":"Thompson, A. J. et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 17, 162\u2013173 (2018).","journal-title":"Lancet Neurol."},{"key":"1683_CR15","doi-asserted-by":"publisher","first-page":"fcae158","DOI":"10.1093\/braincomms\/fcae158","volume":"6","author":"ES Beck","year":"2024","unstructured":"Beck, E. S. et al. Contribution of new and chronic cortical lesions to disability accrual in multiple sclerosis. Brain Commun. 6, fcae158 (2024).","journal-title":"Brain Commun."},{"key":"1683_CR16","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1177\/13524585211069167","volume":"28","author":"ES Beck","year":"2022","unstructured":"Beck, E. S. et al. Cortical lesion hotspots and association of subpial lesions with disability in multiple sclerosis. Mult. Scler. J. 28, 1351\u20131363 (2022).","journal-title":"Mult. Scler. J."},{"key":"1683_CR17","doi-asserted-by":"publisher","first-page":"973","DOI":"10.3389\/fneur.2020.00973","volume":"11","author":"R-A Todea","year":"2020","unstructured":"Todea, R.-A. et al. Evolution of cortical and white matter lesion load in early-stage multiple sclerosis: correlation with neuroaxonal damage and clinical changes. Front. Neurol. 11, 973 (2020).","journal-title":"Front. Neurol."},{"key":"1683_CR18","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1148\/radiol.2019181719","volume":"291","author":"CA Treaba","year":"2019","unstructured":"Treaba, C. A. et al. Longitudinal characterization of cortical lesion development and evolution in multiple sclerosis with 7.0-T MRI. Radiology 291, 740\u2013749 (2019).","journal-title":"Radiology"},{"key":"1683_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-016-0718-9","volume":"16","author":"O Geisseler","year":"2016","unstructured":"Geisseler, O. et al. The relevance of cortical lesions in patients with multiple sclerosis. BMC Neurol. 16, 204 (2016).","journal-title":"BMC Neurol."},{"key":"1683_CR20","doi-asserted-by":"publisher","first-page":"2952","DOI":"10.1093\/brain\/aws246","volume":"135","author":"M Calabrese","year":"2012","unstructured":"Calabrese, M. et al. Cortical lesion load associates with progression of disability in multiple sclerosis. Brain 135, 2952\u20132961 (2012).","journal-title":"Brain"},{"key":"1683_CR21","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1001\/jamaneurol.2020.4689","volume":"78","author":"M Filippi","year":"2021","unstructured":"Filippi, M. et al. Diagnosis of progressive multiple sclerosis from the imaging perspective: a review. JAMA Neurol. 78, 351 (2021).","journal-title":"JAMA Neurol."},{"key":"1683_CR22","doi-asserted-by":"publisher","first-page":"459","DOI":"10.3174\/ajnr.A5534","volume":"39","author":"ES Beck","year":"2018","unstructured":"Beck, E. S. et al. Improved visualization of cortical lesions in multiple sclerosis using 7T MP2RAGE. Am. J. Neuroradiol. 39, 459\u2013466 (2018).","journal-title":"Am. J. Neuroradiol."},{"key":"1683_CR23","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.3174\/ajnr.A6099","volume":"40","author":"J Maranzano","year":"2019","unstructured":"Maranzano, J. et al. Comparison of multiple sclerosis cortical lesion types detected by multicontrast 3T and 7T MRI. Am. J. Neuroradiol. 40, 1162\u20131169 (2019).","journal-title":"Am. J. Neuroradiol."},{"key":"1683_CR24","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1212\/WNL.0b013e31820a0cc4","volume":"76","author":"JJG Geurts","year":"2011","unstructured":"Geurts, J. J. G. et al. Consensus recommendations for MS cortical lesion scoring using double inversion recovery MRI. Neurology 76, 418\u2013424 (2011).","journal-title":"Neurology"},{"key":"1683_CR25","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1136\/jnnp-2012-303023","volume":"83","author":"V Sethi","year":"2012","unstructured":"Sethi, V. et al. Improved detection of cortical MS lesions with phase-sensitive inversion recovery MRI. J. Neurol. Neurosurg. Psychiatry 83, 877\u2013882 (2012).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"1683_CR26","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1097\/RLI.0000000000000698","volume":"55","author":"ES Beck","year":"2020","unstructured":"Beck, E. S. et al. Inversion recovery susceptibility weighted imaging with enhanced T2 weighting at 3 T improves visualization of subpial cortical multiple sclerosis lesions. Investig. Radiol. 55, 727\u2013735 (2020).","journal-title":"Investig. Radiol."},{"key":"1683_CR27","doi-asserted-by":"publisher","first-page":"259","DOI":"10.3174\/ajnr.A4514","volume":"37","author":"V Wiggermann","year":"2016","unstructured":"Wiggermann, V., Hern\u00e1ndez-Torres, E., Traboulsee, A., Li, D. K. B. & Rauscher, A. FLAIR2: a combination of FLAIR and T2 for improved MS lesion detection. Am. J. Neuroradiol. 37, 259\u2013265 (2016).","journal-title":"Am. J. Neuroradiol."},{"key":"1683_CR28","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1111\/jon.13088","volume":"33","author":"AR Manning","year":"2023","unstructured":"Manning, A. R. et al. T1 \/T2 ratio from 3T MRI improves multiple sclerosis cortical lesion contrast. J. Neuroimaging J. Am. Soc. Neuroimaging 33, 434\u2013445 (2023).","journal-title":"J. Neuroimaging J. Am. Soc. Neuroimaging"},{"key":"1683_CR29","doi-asserted-by":"crossref","unstructured":"Bouman, P. M. et al. Multicenter evaluation of AI-generated DIR and PSIR for cortical and juxtacortical multiple sclerosis lesion detection. Radiology 307, 221425 (2023).","DOI":"10.1148\/radiol.221425"},{"key":"1683_CR30","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1177\/13524585211029860","volume":"28","author":"PM Bouman","year":"2022","unstructured":"Bouman, P. M. et al. Artificial double inversion recovery images for (juxta)cortical lesion visualization in multiple sclerosis. Mult. Scler. J. 28, 541\u2013549 (2022).","journal-title":"Mult. Scler. J."},{"key":"1683_CR31","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1056\/NEJMoa1606468","volume":"376","author":"X Montalban","year":"2017","unstructured":"Montalban, X. et al. Ocrelizumab versus placebo in primary progressive multiple sclerosis. N. Engl. J. Med. 376, 209\u2013220 (2017).","journal-title":"N. Engl. J. Med."},{"key":"1683_CR32","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1109\/TMI.2010.2046908","volume":"29","author":"NJ Tustison","year":"2010","unstructured":"Tustison, N. J. et al. N4ITK: improved N3 bias correction. Med. Imaging IEEE Trans. 29, 1310\u20131320 (2010).","journal-title":"Med. Imaging IEEE Trans."},{"key":"1683_CR33","first-page":"58","volume":"9","author":"G Grabner","year":"2006","unstructured":"Grabner, G. et al. Symmetric atlasing and model based segmentation: an application to the hippocampus in older adults. MICCAI Int. Conf. Med. Image Comput. Comput. Assist. Inter. 9, 58\u201366 (2006).","journal-title":"MICCAI Int. Conf. Med. Image Comput. Comput. Assist. Inter."},{"key":"1683_CR34","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.neuroimage.2011.09.015","volume":"62","author":"M Jenkinson","year":"2012","unstructured":"Jenkinson, M., Beckmann, C. F., Behrens, T. E. J., Woolrich, M. W. & Smith, S. M. FSL. NeuroImage 62, 782\u2013790 (2012).","journal-title":"NeuroImage"},{"key":"1683_CR35","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/hbm.10062","volume":"17","author":"SM Smith","year":"2002","unstructured":"Smith, S. M. Fast robust automated brain extraction. Hum. Brain Mapp. 17, 143\u2013155 (2002).","journal-title":"Hum. Brain Mapp."},{"key":"1683_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2020.117012","volume":"219","author":"L Henschel","year":"2020","unstructured":"Henschel, L. et al. FastSurfer - a fast and accurate deep learning based neuroimaging pipeline. NeuroImage 219, 117012 (2020).","journal-title":"NeuroImage"},{"key":"1683_CR37","doi-asserted-by":"publisher","first-page":"4379","DOI":"10.1212\/WNL.96.15_supplement.4379","volume":"96","author":"N Bergsland","year":"2021","unstructured":"Bergsland, N., Jakimovski, D., Ramasamy, D., Zivadinov, R. & Dwyer, M. A deep learning-based approach for simultaneously segmenting T2 lesions and T1 hypointensities in multiple sclerosis regulatory clinical trials (4379). Neurology 96, 4379 (2021).","journal-title":"Neurology"},{"key":"1683_CR38","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1006\/nimg.2002.1040","volume":"17","author":"SM Smith","year":"2002","unstructured":"Smith, S. M. et al. Accurate, robust, and automated longitudinal and cross-sectional brain change analysis. NeuroImage 17, 479\u2013489 (2002).","journal-title":"NeuroImage"},{"key":"1683_CR39","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s00415-021-10833-x","volume":"269","author":"T Zrzavy","year":"2022","unstructured":"Zrzavy, T. et al. FLAIR2 post-processing: improving MS lesion detection in standard MS imaging protocols. J. Neurol. 269, 461\u2013467 (2022).","journal-title":"J. Neurol."},{"key":"1683_CR40","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.media.2007.06.004","volume":"12","author":"BB Avants","year":"2008","unstructured":"Avants, B. B., Epstein, C. L., Grossman, M. & Gee, J. C. Symmetric diffeomorphic image registration with cross-correlation: Evaluating automated labeling of elderly and neurodegenerative brain. Med. Image Anal. 12, 26\u201341 (2008).","journal-title":"Med. Image Anal."},{"key":"1683_CR41","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1148\/radiol.2501080480","volume":"250","author":"B Moraal","year":"2009","unstructured":"Moraal, B. et al. Subtraction MR images in a multiple sclerosis multicenter clinical trial setting. Radiology 250, 506\u2013514 (2009).","journal-title":"Radiology"},{"key":"1683_CR42","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1016\/j.mri.2012.05.001","volume":"30","author":"A Fedorov","year":"2012","unstructured":"Fedorov, A. et al. 3D Slicer as an image computing platform for the Quantitative Imaging Network. Magn. Reson. Imaging 30, 1323\u20131341 (2012).","journal-title":"Magn. Reson. Imaging"},{"key":"1683_CR43","doi-asserted-by":"crossref","unstructured":"Hatamizadeh, A. et al. Swin UNETR: swin transformers for semantic segmentation of brain tumors in MRI images. International MICCAI brainlesion workshop. (Springer International Publishing, Cham, 2021).","DOI":"10.1007\/978-3-031-08999-2_22"},{"key":"1683_CR44","doi-asserted-by":"publisher","first-page":"104791","DOI":"10.1016\/j.bspc.2023.104791","volume":"84","author":"H Xiao","year":"2023","unstructured":"Xiao, H., Li, L., Liu, Q., Zhu, X. & Zhang, Q. Transformers in medical image segmentation: a review. Biomed. Signal. Process. Control 84, 104791 (2023).","journal-title":"Biomed. Signal. Process. Control"},{"key":"1683_CR45","doi-asserted-by":"crossref","unstructured":"Tang, Y. et al. Self-supervised pre-training of swin transformers for 3D medical image analysis. Proceedings of the IEEE\/CVF conference on computer vision and pattern recognition. 20730\u201320740 (2022).","DOI":"10.1109\/CVPR52688.2022.02007"},{"key":"1683_CR46","doi-asserted-by":"publisher","unstructured":"Loshchilov, I. & Hutter, F. Decoupled weight decay regularization. Preprint at. https:\/\/doi.org\/10.48550\/arXiv.1711.05101 (2019).","DOI":"10.48550\/arXiv.1711.05101"},{"key":"1683_CR47","doi-asserted-by":"publisher","first-page":"102026","DOI":"10.1016\/j.compmedimag.2021.102026","volume":"95","author":"M Yeung","year":"2022","unstructured":"Yeung, M., Sala, E., Sch\u00f6nlieb, C.-B. & Rundo, L. Unified focal loss: generalising Dice and cross entropy-based losses to handle class imbalanced medical image segmentation. Comput. Med. Imaging Graph. 95, 102026 (2022).","journal-title":"Comput. Med. Imaging Graph."},{"key":"1683_CR48","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/s41592-023-02150-0","volume":"21","author":"A Reinke","year":"2024","unstructured":"Reinke, A. et al. Understanding metric-related pitfalls in image analysis validation. Nat. Methods 21, 182\u2013194 (2024).","journal-title":"Nat. Methods"},{"key":"1683_CR49","doi-asserted-by":"crossref","unstructured":"Raina, V. et al. Tackling bias in the Dice similarity coefficient: introducing nDSC for white matter lesion segmentation. IEEE 20th International Symposium on Biomedical Imaging (2023).","DOI":"10.1109\/ISBI53787.2023.10230755"},{"key":"1683_CR50","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1136\/jnnp-2023-332573","volume":"95","author":"R Zivadinov","year":"2024","unstructured":"Zivadinov, R. et al. Evolution of atrophied T2 lesion volume in primary-progressive multiple sclerosis: results from the phase 3 ORATORIO study. J. Neurol. Neurosurg. Psychiatry 95, 536\u2013543 (2024).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"1683_CR51","doi-asserted-by":"publisher","first-page":"30088","DOI":"10.1073\/pnas.1907377117","volume":"117","author":"V Antun","year":"2020","unstructured":"Antun, V., Renna, F., Poon, C., Adcock, B. & Hansen, A. C. On instabilities of deep learning in image reconstruction and the potential costs of AI. Proc. Natl. Acad. Sci. 117, 30088\u201330095 (2020).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"1683_CR52","doi-asserted-by":"publisher","first-page":"102335","DOI":"10.1016\/j.nicl.2020.102335","volume":"27","author":"F La Rosa","year":"2020","unstructured":"La Rosa, F. et al. Multiple sclerosis cortical and WM lesion segmentation at 3T MRI: a deep learning method based on FLAIR and MP2RAGE. NeuroImage Clin. 27, 102335 (2020).","journal-title":"NeuroImage Clin."},{"key":"1683_CR53","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1177\/1352458510394702","volume":"18","author":"M Calabrese","year":"2012","unstructured":"Calabrese, M. et al. Effect of disease-modifying drugs on cortical lesions and atrophy in relapsing\u2013remitting multiple sclerosis. Mult. Scler. J. 18, 418\u2013424 (2012).","journal-title":"Mult. Scler. J."},{"key":"1683_CR54","doi-asserted-by":"publisher","first-page":"133","DOI":"10.3389\/fneur.2019.00133","volume":"10","author":"TD Faizy","year":"2019","unstructured":"Faizy, T. D. et al. Development of cortical lesion volumes on double inversion recovery mri in patients with relapse-onset multiple sclerosis. Front. Neurol. 10, 133 (2019).","journal-title":"Front. Neurol."}],"container-title":["Communications Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43856-026-01683-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-026-01683-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-026-01683-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T09:02:34Z","timestamp":1783414954000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43856-026-01683-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,7]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1683"],"URL":"https:\/\/doi.org\/10.1038\/s43856-026-01683-7","relation":{},"ISSN":["2730-664X"],"issn-type":[{"value":"2730-664X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,7]]},"assertion":[{"value":"31 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.G.D. has received research grants from Novartis, Bristol Myers Squibb, Mapi Pharma, Merck Serono, Keystone Heart Ltd., Protembis GmbH, and V-Wave Ltd., and consulting fees from Bristol Myers Squibb, Merck Serono, and Keystone Heart Ltd. NB serves on the editorial board of Neurology and Journal of Neuroimaging. He has received compensation for serving as a deputy editor for Journal of Magnetic Resonance Imaging. He has received research support from Genentech. A.B. and D.J. have nothing to report. S.N. has received research grants from Atara Biotherapeutics, Merck, and Biogen. M.D.S. has received research grants from Atara Biotherapeutics, Merck, and Biogen. M.M.S. serves on the editorial board of Neurology and Frontiers in Neurology and Multiple Sclerosis Journal, receives research support from the Dutch MS Research Foundation, Eurostars-EUREKA, ARSEP, Amsterdam Neuroscience, MAGNIMS, and ZonMW and has served as a consultant for or received research support from EIP Pharma, Atara Biotherapeutics, Biogen, Celgene\/Bristol Meyers Squibb, Genzyme, MedDay, and Merck. J.P. and D.C. are employees of Genentech, Inc. R.Z. received personal compensation from Bristol Myers Squibb, EMD Serono, Sanofi, Janssen, Biogen, Filterlex for speaking and consultant fees. He received financial support for research activities from Sanofi, Novartis, Bristol Myers Squibb, Octave, Mapi Pharma, CorEvitas, Protembis, Filterlex and V-WAVE Medical.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"365"}}